De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
about
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@en
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@nl
type
label
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@en
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@nl
prefLabel
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@en
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@nl
P2093
P2860
P356
P1476
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
@en
P2093
Hakan Gunaydin
Matthew M Weiss
Yaxiong Sun
P2860
P304
P356
10.1021/ML300314H
P577
2012-11-06T00:00:00Z